Yali Zhai

4.2k total citations · 1 hit paper
32 papers, 3.3k citations indexed

About

Yali Zhai is a scholar working on Molecular Biology, Reproductive Medicine and Oncology. According to data from OpenAlex, Yali Zhai has authored 32 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Reproductive Medicine and 8 papers in Oncology. Recurrent topics in Yali Zhai's work include Ovarian cancer diagnosis and treatment (11 papers), Wnt/β-catenin signaling in development and cancer (7 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Yali Zhai is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Wnt/β-catenin signaling in development and cancer (7 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Yali Zhai collaborates with scholars based in United States, Japan and China. Yali Zhai's co-authors include Kathleen R. Cho, Eric R. Fearon, Rork Kuick, Rong Wu, Guido T. Bommer, Thomas J. Giordano, Ying Feng, Zhaohui Qin, Robert Love and Isabelle Gerin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Yali Zhai

30 papers receiving 3.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes

2007 918 citations Guido T. Bommer, Ying Feng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yali Zhai United States	21	2.3k	1.3k	721	621	360	32	3.3k
Pamela M. Pollock Australia	34	2.6k 1.1×	884 0.7×	1.3k 1.9×	438 0.7×	405 1.1×	90	4.0k
Sílvia Menéndez United States	32	2.5k 1.1×	903 0.7×	1.2k 1.6×	389 0.6×	188 0.5×	76	4.0k
Anne M. Øyan Norway	37	1.6k 0.7×	769 0.6×	809 1.1×	254 0.4×	163 0.5×	75	2.9k
Margaret C. Cummings Australia	32	1.5k 0.6×	1.0k 0.8×	1.4k 2.0×	198 0.3×	735 2.0×	74	3.2k
Olga Aprelikova United States	30	2.8k 1.2×	1.1k 0.9×	1.0k 1.4×	229 0.4×	163 0.5×	48	3.7k
Regina S. Whitaker United States	34	2.2k 0.9×	877 0.7×	1.7k 2.3×	1.5k 2.4×	398 1.1×	72	4.3k
Leah Prentice Canada	18	909 0.4×	456 0.4×	552 0.8×	1.0k 1.7×	268 0.7×	26	2.2k
Yusuke Nakamura Japan	27	1.5k 0.6×	627 0.5×	773 1.1×	206 0.3×	468 1.3×	84	2.7k
Michael S. Anglesio Canada	32	1.5k 0.6×	737 0.6×	652 0.9×	1.8k 3.0×	545 1.5×	71	3.6k
Patricia N. Tonin Canada	37	2.7k 1.2×	1.0k 0.8×	1.2k 1.6×	801 1.3×	732 2.0×	127	4.5k

Countries citing papers authored by Yali Zhai

Since Specialization

Citations

This map shows the geographic impact of Yali Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali Zhai more than expected).

Fields of papers citing papers by Yali Zhai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yali Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali Zhai. The network helps show where Yali Zhai may publish in the future.

Co-authorship network of co-authors of Yali Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Yali Zhai. A scholar is included among the top collaborators of Yali Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yali Zhai. Yali Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feng, Ying, Karan Bedi, Maranne Green, et al.. (2025). SOX9 suppresses colon cancer via inhibiting epithelial-mesenchymal transition and SOX2 induction. Journal of Clinical Investigation. 135(11). 1 indexed citations

Zhai, Yali, Eric R. Fearon, & Kathleen R. Cho. (2025). Bilateral Salpingo-Oophorectomy Is Superior to Salpingectomy Alone in Preventing Non-Tubal Tumor Development in a Mouse Model of High-Grade Serous Carcinoma. Cancers. 17(17). 2759–2759.

Zhai, Yali, Kevin Hu, Aaron M. Udager, et al.. (2022). Aging accelerates while multiparity delays tumorigenesis in mouse models of high-grade serous carcinoma. Gynecologic Oncology. 165(3). 552–559. 7 indexed citations

Chen, Lixing, Yali Zhai, Yisheng Wang, et al.. (2021). Altering the Microbiome Inhibits Tumorigenesis in a Mouse Model of Oviductal High-Grade Serous Carcinoma. Cancer Research. 81(12). 3309–3318. 27 indexed citations

McCool, Kevin W., Zachary T. Freeman, Yali Zhai, et al.. (2019). Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts. Cancer Research. 80(4). 877–889. 17 indexed citations

Zhai, Yali, Rong Wu, Rork Kuick, et al.. (2017). High‐grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease. The Journal of Pathology. 243(1). 16–25. 67 indexed citations

Bitler, Benjamin G., Shuai Wu, Pyoung Hwa Park, et al.. (2017). ARID1A-mutated ovarian cancers depend on HDAC6 activity. Nature Cell Biology. 19(8). 962–973. 172 indexed citations

Wu, Rong, Yali Zhai, Rork Kuick, et al.. (2016). Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse. The Journal of Pathology. 240(3). 341–351. 49 indexed citations

McDaniel, Andrew S., Daniel H. Hovelson, Andi K. Cani, et al.. (2015). Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy. Cancer Research. 75(24). 5219–5227. 86 indexed citations

10.

Zhai, Yali, Rork Kuick, Rong Wu, et al.. (2015). Arid1a inactivation in an Apc‐ and Pten‐defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival. The Journal of Pathology. 238(1). 21–30. 40 indexed citations

11.

Feng, Ying, Naoya Sakamoto, Rong Wu, et al.. (2015). Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian Epithelium. PLoS Genetics. 11(11). e1005638–e1005638. 17 indexed citations

12.

McDaniel, Andrew S., Yali Zhai, Kathleen R. Cho, et al.. (2014). HRAS mutations are frequent in inverted urothelial neoplasms. Human Pathology. 45(9). 1957–1965. 27 indexed citations

13.

Feng, Ying, Guido T. Bommer, Jenny Zhao, et al.. (2011). Mutant Kras Promotes Hyperplasia and Alters Differentiation in the Colon Epithelium but Does Not Expand the Presumptive Stem Cell Pool. Gastroenterology. 141(3). 1003–1013.e10. 99 indexed citations

14.

Sluis, Bart van de, Xicheng Mao, Yali Zhai, et al.. (2010). COMMD1 disrupts HIF-1α/β dimerization and inhibits human tumor cell invasion. Journal of Clinical Investigation. 120(6). 2119–2130. 103 indexed citations

15.

Zhai, Yali, Rork Kuick, Bin Nan, et al.. (2007). Gene Expression Analysis of Preinvasive and Invasive Cervical Squamous Cell Carcinomas Identifies HOXC10 as a Key Mediator of Invasion. Cancer Research. 67(21). 10163–10172. 203 indexed citations

16.

Zhai, Yali, Rong Wu, Donald R. Schwartz, et al.. (2002). Role of β-Catenin/T-Cell Factor-Regulated Genes in Ovarian Endometrioid Adenocarcinomas. American Journal Of Pathology. 160(4). 1229–1238. 88 indexed citations

17.

Schwartz, Donald R., Sharon L. R. Kardia, Kerby Shedden, et al.. (2002). Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.. PubMed. 62(16). 4722–9. 348 indexed citations

18.

Kolligs, Frank T., Marvin T. Nieman, Ira Winer, et al.. (2002). ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with β-catenin defects and promotes neoplastic transformation. Cancer Cell. 1(2). 145–155. 125 indexed citations

19.

Leung, Janet Y., Frank T. Kolligs, Rong Wu, et al.. (2002). Activation of AXIN2 Expression by β-Catenin-T Cell Factor. Journal of Biological Chemistry. 277(24). 21657–21665. 307 indexed citations

20.

Kawa, Shigeyuki, Toshio Nikaido, Yuji Aoki, et al.. (1997). Arotinoid mofarotene (RO40-8757) up-regulates p21 and p27 during growth inhibition of pancreatic cancer cell lines. International Journal of Cancer. 72(5). 906–911. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact